The damage to DNA by the hepatocarcinogen aflatoxin B1 was investigated. A DNA fragment of known sequence of the lactose promoter-operator region was used as a substrate for modification by aflatoxin B1. The DNA was incubated with aflatoxin B1 in crude mammalian liver extracts or with purified microsomes. Treatment of the DNA incubated in the complete system with either 1 M piperidine or 0.1 M NaOH at 900 revealed alkali-labile lesions in the DNA. The exact location of the cleavage site was determined by comparison of the length of the cleavage products with the known sequence on polyacrylamide gels. The lengths of the cleavage products were the same as those produced by alkali-induced breakage of the same sequence of DNA that had been modified with dimethyl sulfate. The major cleavage products of the aflatoxin B1-modified DNA were at positions of guanine and the minor cleavage products were at positions of adenine. These studies show that modification of DNA by aflatoxin B1 creates alkali-labile sites at positions of guanine and, to a lesser extent, adenine.
NaOH at 900 revealed alkali-labile lesions in the DNA. The exact location of the cleavage site was determined by comparison of the length of the cleavage products with the known sequence on polyacrylamide gels. The lengths of the cleavage products were the same as those produced by alkali-induced breakage of the same sequence of DNA that had been modified with dimethyl sulfate. The major cleavage products of the aflatoxin B1-modified DNA were at positions of guanine and the minor cleavage products were at positions of adenine. These studies show that modification of DNA by aflatoxin B1 creates alkali-labile sites at positions of guanine and, to a lesser extent, adenine.
Aflatoxin B1 (AFB1), a difuranocoumarin metabolite of some strains of the mold Aspergillus flavus, is a potent liver toxin and carcinogen (1) and a powerful mutagen in in vitro tests (2) . Epidemiological studies associate AFB1 in the diet with a high incidence of human liver cancer in Thailand and West Africa (3) . Several lines of evidence indicate that AFB1 requires metabolic activation for biological activity (1, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . For example, Ames et al. (2) have demonstrated that the mutagenic activity of AFB1 in a Salmonella reversion test requires activation by liver microsomes. Labeled AFB1 binds covalently to both DNA and proteins in vivo and in vitro after metabolic activation, and it is likely that AFB,-2,3-oxide is a major intermediate in these reactions. Swenson et al. (11) have isolated 2,3-dihydro-2,3-dihydroxy AFB1 after acid hydrolysis of nucleic acids extracted from the livers of rats injected with AFB1 and from the nucleic acids treated with AFB1 in the presence of rat and human microsomes.
Recently, Essigman et al. (15) and Lin et al. (16) identified the principal DNA adduct of AFB1 as 2,3-dihydro-2-(N7-guanyl)-3-hydroxy AFB,. This adduct accounts for 90% of the binding to DNA when AFB1 is incubated with DNA in the presence of activating enzymes. Essigman et al. (15) note that the N7-guanine AFB.1 adduct, like the N7-alkylguanines, is expected to weaken the N-glycosylic bond because the corresponding nucleotide carries a positive charge. If this were the case, then treatment of the modified DNA at elevated temperatures with alkali should cleave the phosphodiester bond at the site of modification. Exposure of depurinated DNA to 0.1 M NaOH at elevated temperatures results in cleavage of the phosphodiester bond on the 3' side of depurination by a 0-elimination reaction (17) . Treatment of DNA alkylated at the N7-guanine with 1 M piperidine also results in breakage of the N-glycosylic bond and scission of the phosphodiester bond 3' to the modified base.
To test this hypothesis we incubated a DNA fragment of known length and sequence, labeled at the 5' end with 32P, with activating enzymes in the presence and absence of AFB1. The DNA was isolated from the reaction mixture and the length of the DNA products was analyzed on high-resolution, denaturing polyacrylamide gels before and after alkaline hydrolysis or after treatment with piperidine. Because the DNA is labeled only at the 5' end and because the sequence of the DNA is known, the length of the labeled cleavage products reveals the position at which cleavage has occurred and, hence, the identity of the modified base. To facilitate identification of the nucleotide at the site of cleavage, we ran the products produced by reaction of the same DNA sequence with dimethyl sulfate (Me2SO4) on parallel slots of a slab gel. Under the reaction conditions used, treatment of the DNA with Me2SO4 followed by piperidine hydrolysis results in breakage of DNA at guanine residues (18) .
The experiments reported here demonstrate that activated AFB1 creates alkali-labile lesions in DNA at positions of guanine and, to a lesser extent, adenine. The method of identification of the sites of modification of DNA by activated AFB1 used here may be useful in similar studies of the site of modification of DNA by other mutagenic and carcinogenic agents.
MATERIALS AND METHODS
Liver and Microsome Extracts. Liver extracts and microsomes were prepared from phenobarbital-treated male Fischer rats by the procedure of Kinoshita et al. (19) . The protein concentration of the microsomal preparation was 40 mg/ml. A crude S-9 mammalian liver extract was prepared by the procedure of Ames et al. (2) from phenobarbital-treated rats and from nonphenobarbital-treated (C57B1) mice (Jackson Labs). Microsomal preparations were frozen in 250-g, aliquots, and crude S-9 extract was frozen in 1-ml aliquots at -70°until used. The microsomal reaction mixture (0.2 ml) was composed of 45 mM Tris-HCl (pH 7.5), 3 mM MgCl2, 5 mM glucose-6-phosphate, 0.8 mM NADP (Sigma Chemical Co.), 0.4 unit of glucose-6-phosphate dehydrogenase (Sigma Chemical Co.) per ml, 250 ,l of microsomal preparation per 1 ml of mixture, and 5 ,g of sonicated salmon sperm DNA per ml. The S-9 incubation mixture contained the same concentrations as the microsomal mixture, except that glucose-6-phosphate dehydrogenase was omitted and the mixture contained 0.3 ml of S-9 fraction per ml in place of purified microsomes.
AFB1 (Sigma Chemical Co.) was added from a stock solution in dimethyl sulfoxide (5 mg/ml) and concentrations were adjusted to those specified in the figure legends. Preparation of Aflatoxinated DNA. Terminally labeled DNA was added to the reaction mixture in 5 ,gl of 10 mM Tris.HCl/0.1 mM EDTA, pH 7.4. The reaction mixtures were incubated at 370 for 30 min and reactions were terminated by addition of sodium dodecyl sulfate (12.5 ,l of 10% stock). The DNA was deproteinized by addition of 25 ,l of a 1 mg/ml stock of Pronase to each reaction mixture and incubation at 370 for 30 min. followed by four phenol extractions and one ether extraction. The aqueous phase was then adjusted to 0.3 M sodium acetate and 10 ,gg of yeast tRNA per ml, and the labeled DNA was recovered by ethanol precipitation. The DNA was then hydrolyzed by treatment 1 (1 M piperidine for 30 min at 900) or treatment 2 (15 min at 900 in 10 mM sodium phosphate/0.1 mM EDTA, pH 7.0 followed by treatment with 0.1 M NaOH for 30 min at 90°.) Such prior heat treatment at neutral pH would be expected to depurinate DNA at sites of alkylated purines (18) . The DNA was recovered, purified, and resuspended in gel loading buffer.
Preparation of Specific Labeled DNA Fragments. The DNA of known sequence used was a segment of the control region of the lactose operon of Escherichia coli (20) . A strain (MM294) of E. coli (20) contained the pLJ-3 plasmid, a pMB9 plasmid with a 285-base-pair insert that was made by L Johnsrud (personal communication). The 285-base-pair insert contains two copies of the lactose operon promotor-operator sequence, one copy at each end and both containing the UV-5 mutation (21, 22) . Milligram quantities of this plasmid can be isolated by purification procedures similar to those of Tanaka and Weisblum (23) .
The purified plasmid DNA was cleaved with the restriction endonuclease EcoRI (New England Bio Labs), producing two fragments, a large fragment, which is the linear form of the pMB9 plasmid, and the 285-base-pair insert (Fig. 1 ). This smaller fragment was isolated on! a 7.5% Tris borate/polyacrylamide gel and eluted. The labeled fragment. was prepared by incubating the 285-base-pair fragment with bacterial alkaline phosphatase (Boehringer Mannheim), followed by incubation with [y-32P]ATP (10 times excess molar equivalent of DNA 5' ends, 1250 Ci/mmol) and polynucleotide kinase (Biolabs) as described' by 'Maxam and Gilbert (18) . Because the two copies of the lactose operon promotor-operator (lac p-o) region have the same polarity and are at the two ends of the 285-base-pair fragment, the 5' ends of both strands can be labeled (Fig. 2) . The 285-base-pair fragment had a specific activity of
RESULTS
To determine whether AFBj adducts of DNA cause alkali-labile lesions at specific nucleotides, we prepared a DNA substrate suitable for such studies. The substrate chosen was a 117-or 168-nucleotide-long DNA fragment that contained the control region, the operator and promoter sequences, of the lactose operon. This substrate was selected because the sequence of the DNA has been determined (20, 22) and because it can be prepared in large quantities from bacteria that contain the sequence on the pLJ3 plasmid made by L. Johnsrud. The lac promoter-operator sequence is present on the plasmid in two copies, and this region of the plasmid is flanked by recognition sequences for the restriction enzyme EcoRI. Asymetrically situated between the two EcoRI recognition sites (117 nucleotides from one end and 168 nucleotides from the other end) is the recognition sequence for the restriction endonuclease Hae III. If the 285-nucleotide-long fragment is first 5'-end-labeled with 32P by incubation with bacterial alkaline phosphatase, followed by reaction with [-y-32P]ATP in the presence of polynucleotide kinase, and is then treated with the endonuclease Hae III, two DNA fragments labeled only at the 5' end of one strand are produced (Fig. 1) . The 117-and 168-nucleotide-long fragments are easily separated by electrophoresis on a nondenaturing polyacrylamide gel. Opposite strands of the sequence are labeled on the two fragments (Fig. 2) . If an agent cleaves a specific phosphodiester bond within the lactose promotoroperator, the precise site of strand breakage can be ascertained simply by determining the length of the 5'-end-labeled product because the sequence of the DNA is known.
In the experiment pictured in Fig. 3 the 168-nucleotidelong, 5'-32P-end-labeled DNA fragment was incubated with AFB1 in the presence or absence of activating enzymes. The activation system used in this experiment was a crude extract (S-9) prepared from the liver of a phenobarbital-treated rat. Control experiments included the same DNA sequence incubated with AFB1 alone and the activating enzyme mixture alone. The DNA was extracted, deproteinized, and denatured and portions were layered directly onto a denaturing polyacrylamide/7 M urea gel. Such (20, 22) . The 117-nucleotide-long fragment is the product of the left-hand side of the DNA fragment of Fig. 1 after cleavage by the restriction endonuclease Hae III; the 168-nucleotide-long fragment is the product of the right-hand side. The primed and unprimed numbers distinguish the two strands.
Biochemistry The DNA incubated with AFB1 in the absence of the activation system was not susceptible to strand scission by treatment 1 or treatment 2 (Fig. 3, lanes 6 and 7) . Activation of AFB1 is therefore required for the appearance of these lesions. Some degradation of the DNA substrate by enzymes in the rat liver S-9 preparation occurs, as shown by the presence of DNA products shorter than full length in the reactions that did not include AFB1 (Fig. 3, lanes 1 and 2) . The degradation is probably the result of endonuclease and 3'-exonuclease activities present in the rat liver extracts. Incubation of the DNA with the rat liver extracts does not create piperidine-sensitive lesions (compare lanes 1 and 2 of Fig. 3 ).
When the DNA extracted from reactions that contained both AFB1 and the rat liver extract was denatured and layered onto the gel without sustained treatment with 0.1 M NaOH, it showed only faint traces of AFB,-induced cleavage (Fig. 3, lane 3). Thus, activated AFB1 does not directly break phosphodiester bonds. Brief treatment of the sample with 0.1 M NaOH at 900, a step that immediately precedes layering onto the gel, would result in strand scission at apurinic sites if such occurred (unpublished observation). Therefore, it is unlikely that the DNA contains a significant number of apurinic sites. The DNA extracted from this reaction probably contains guanosine-AFB, adducts, as reported by Essigman et al. (15) and Lin et al. (16) .
To determine whether all the guanine residues of a DNA sequence were susceptible to modification by activated AFB1, we incubated the 117-nucleotide-long DNA fragment with AFB, in the presence of an extract (S-9) from the liver of a normal mouse. As controls, the DNA was incubated with either the mouse liver extract alone or with AFB, alone. After the reaction, the DNA was deproteinized and treated with 1 M piperidine at 900 before it was analyzed on the denaturing polyacrylamide gels. To observe breakage along the entire sequence we divided the samples into two portions and electrophoresed each for 7 or 20 hr. The longer electrophoresis time permitted the DNA cleavage products of higher molecular weight to be resolved as distinct bands on the gel. As before, incubation of the DNA with AFB1 resulted in piperidine-sensitive lesions at guanine residues (Fig. 4) . All possible guanine cleavages are represented in lanes 2. This demonstrates that all the guanine residues of the template were accessible to modification by activated AFB1. However, the rate of reaction of individual guanines with AFB1 varies, as is apparent from the variation in the relative intensity of the bands (Fig. 4, lanes 2) . The intensity of each band reflects the frequency of cleavage at the corresponding site because each molecule is labeled with 32p only at the 5' terminus. The degradation of the DNA in the absence of AFB1 by the mouse liver extract was not as great as that observed with the rat liver extract. We have found that degradation of the template by crude (S-9) liver extracts or purified liver microsomes varies from experiment to experiment. The DNA degradation activities were enhanced by freezing and thawing the S-9 extracts or by incubation of the S-9 extracts or microsomes at 00. Minimum degradation is achieved by the immediate use of fresh preparations. In the experiments reported here, over 50% of the 5'-32p was retained as acid-precipitable material after incubation with the activating enzymes. _..
Cleavage of DNA at all guanine residues. A 117-nucleotide-long, 5'_32P end-labeled DNA fragment of the lac promoteroperator region (60,000 cpm, 1 ng of DNA per reaction) was incubated with 300 ,gM AFB1 in the presence of incubation mixture prepared from the liver of a non-phenobarbital-treated mouse. The DNA was deproteinized and analyzed on a denaturing 20% polyacrylamide/7 M urea gel. All samples were treated with 1 M piperidine for 30 min at 900. Reactions that contained the liver extract and DNA alone (lane 1), or DNA and liver extract and 300 MM AFB1 (lane 2), or DNA and 300MgM AFB1 in the absence of the liver extract (lane 3) were layered on adjacent slots. The reactions were electrophoresed for 7 hr (Left) or 20 hr (Right) at 1000 V to permit analysis of the entire sequence. The positions of the guanine residues indicated were determined by electrophoresis of the products of a Me2SO4 reaction on the same gel (not shown). Reactions were for 30 min at 37°.
To determine the results of extensive modification of DNA by AFB1, the 168-nucleotide-long, 5'-32P-end-labeled DNA fragment was incubated with a high concentration of AFB1 (1 mM) in the presence of a microsomal fraction purified from the liver of phenobarbital-treated rats. In parallel reactions, DNA was incubated with either the microsomal fraction alone or with AFB1 alone. After deproteinization and incubation with 1 M piperidine at 90°, the DNA was layered onto a denaturing polyacrylamide gel. A portion of the unmodified 168-nucleotide-long DNA fragment treated with Me2SO4 and subjected to piperidine hydrolysis was layered onto the same gel. The DNA that was incubated with 1 mM AFB1 in the presence of the microsomes underwent extensive cleavage of the DNA, as shown by the almost total disappearance of DNA corresponding to the full-length molecules (Fig. 5, compare lanes 2 and 3) . In this reaction a minor class of cleavage products is evident in addition to the major cleavage sites at the guanine residues. The lengths of these minor products corresponds to the position of the adenine residues within the sequence. We conclude that a minor product of the reaction of AFBI with DNA is the modification of adenines. Perhaps an N3-adenine-AFB, adduct FIG. 5 . Extensive degradation of DNA by AFB1 by purified microsomes that had been activated. A 5'-end-labeled DNA fragment of the lac promoter-operator region 117 nucleotides long (60,000 cpm, 1 ng of DNA per reaction) was incubated with 1 mM AFB1 in the presence of a preparation of 10 mg of microsomal protein per ml and purified by the method of Kinoshita et al. (19) prepared from the liver of phenobarbital-treated rats. After the reaction, the DNA was deproteinized and incubated in 1 M piperidine for 30 min at 900 before it was layered onto a 20% polyacrylamide/urea gel. The cleavage products of the reaction (lane 2) were compared to those produced by incubation of the unmodified DNA fragment with 1 Ml of Me2SO4 in 200 Mul of 50 mM sodium cacodylate, pH 8/10 mM MgCl2/0.1 mM EDTA. After incubation with Me2SO4, the DNA was also treated in 1 M piperidine for 30 min at 900. Also shown are controls in which DNA was incubated with the microsomes in the absence of AFB1 (lane 3) and with 1 mM AFB1 in the absence of the microsomes (lane 4). The DNA of both reactions was treated with 1 M piperidine as described above.
is formed by a mechanism similar to that which yields the N7-guanine adduct. The most favorable sites for alkylation of DNA are the N7-guanine and N3-adenine sites (17) . Moreover, such an adduct would also be expected to introduce a positive charge into the adenine ring structure, weakening the N-glycosylic bond (17) .
The DNA products produced by piperidine treatment of the AFB1-modified DNA were identical in length to those produced by piperidine treatment of the Me2SO4-treated DNA (Fig. 5, compare lanes 1 and 2) . This indicates that the fragments that contain the original 5' end of the DNA have a phosphate at their 3' termini. The mechanism of strand scission by piperidine of DNA methylated by Me2SO4 at N7 position of guanine involves ring opening of the guanine followed by elimination of both phosphates (17 These results are consistent with the recent reports that the N7-guanine adduct comprises about 90% of the reaction products with DNA (15, 16) . As reported here, the reaction with adenine is limited, and this is probably the reason it was not detected previously. It is most likely that the alkali-labile sites we observed are the result of labilization of the N-glycosylic linkage by the N7-guanine and N3-adenine AFB1 adducts. Treatment of such adducts at high temperature with either NaOH or piperidine would be expected to give rise to the cleavage products observed (17) . Ames and his collegues have shown that activated AFB1 causes a high frequency of mutations in tester stains of Salmonella typhimurium that contain frameshift mutations (24) . The tester strains that revert after treatment with AFB1 include TA1537, a strain that most probably reverts by deletion of a G.C base pair, and TA1538 and TA98, strains that probably revert by a deletion of two bases, a G and a C. It is conceivable that the N7-guanine-AFB1 adducts described by Essigman et al. (15) and Lin et al. (16) account for the activity of AFB1 in these strains. The experiments reported here demonstrate that bound AFB1 does destabilize the N-glycosylic bond at positions of guanine as suggested (15) . It is likely that apurinic sites are formed spontaneously at the sites of modified guanine. Repair processes could result in the loss of entire nucleotides at such sites, and this would result in frameshift mutation. The mutagenic effect of bulky N7-guanine adducts has not been investigated. It appears, however, that alkylation by the smaller methyl and ethyl groups is not mutagenic (25) .
AFB1 also causes strain TA100, a strain that contains a missense mutation, torevert. The mechanismby which AFBn causes base substitution mutations is not clear. Apparently the mutagenic activity of AFB1 in the missense tester strain of Salmonella requires the presence of the resistance (R) factor pKM101 (26) . Whatever mechanisms are involved in base substitution or frameshift mutations, the observation reported here that AFB1 also modifies adenine residues suggests that adenines as well as guanines may provide sites for mutagenesis, albeit at a reduced frequency.
The methodology described here should be generally useful for determining the base specificity of agents that damage DNA. The site of action of agents that cleave the phosphodiester bond directly or that create lesions that eventually result in strand scission can be determined rapidly by analysis of the lengths of the cleavage products on polyacrylamide gels. Furthermore, the utility of the method is extended by coupling it with enzyme systems that convert inactive agents to active agents. The enzyme systems used here were rat liver microsomes, crude liver extracts from a normal mouse, and extracts from phenobarbital-treated rats. The same types of enzymes systems have been used by Ames et al. (2) for tests of the requirement for metabolic activation for mutagenic activity of a number of carcinogens.
